The American Academy of Pediatrics has published its first clinical guideline for pediatricians on prescribing opioids, ...

The Pediatric Research Equity Act aims to close the gap in pediatric drug testing but faces significant delays in study completion. Rare disease designations exempt nearly half of new drugs from ...

The American Academy of Pediatrics (AAP) has published its first clinical practice guideline on the use of opioid medications to manage acute pain in children and adolescents.

Researchers sought to determine whether high antimetabolite dose intensity is related to higher treatment-induced toxicity in pediatric patients with ALL.

The FDA could then request drug sponsors to study drugs on the list. Pediatric study results submitted as Supplemental New Drug Applications (SNDA) undergo the same FDA review process as any ...

The safety and efficacy of most commercially available medications have not been well studied in pediatric patients. [1] There is a particular paucity of information on drug use in patients under ...

The American Academy of Pediatrics has published its first clinical guideline for pediatricians on prescribing opioids, including explicit instructions on how and when to prescribe these medications ...

U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation and Rare Pediatric Disease designation for bexicaserin for the treatment of Dravet syndrome LA JOLLA, Calif., ...

The pediatric rare disease priority review voucher program is set to end on Sept. 30. The legislation would extend the program until Sept. 30, 2029. The end of the third quarter is also the end ...

A medical assistant employed by a North Texas pediatrics practice is accused of sexually abusing multiple children during their medical examinations, according to Irving police. The suspect, ...

according to new research presented during the American Academy of Pediatrics 2024 National Conference & Exhibition. The abstract, "Chroming Crisis: An Analysis of Chroming Related Content on ...